JP2021505669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505669A5 JP2021505669A5 JP2020550040A JP2020550040A JP2021505669A5 JP 2021505669 A5 JP2021505669 A5 JP 2021505669A5 JP 2020550040 A JP2020550040 A JP 2020550040A JP 2020550040 A JP2020550040 A JP 2020550040A JP 2021505669 A5 JP2021505669 A5 JP 2021505669A5
- Authority
- JP
- Japan
- Prior art keywords
- range
- pharmaceutical composition
- amount
- dexamethasone
- dosing regimen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 13
- 229960003957 dexamethasone Drugs 0.000 claims 13
- ZBRAJOQFSNYJMF-SFHVURJKSA-N (1s)-1-[6,7-bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2h-triazol-4-yl)propan-1-ol Chemical compound C1([C@](O)(C(C)C)C=2C=C3C=C(OC(F)F)C(OC(F)F)=CC3=CC=2)=CNN=N1 ZBRAJOQFSNYJMF-SFHVURJKSA-N 0.000 claims 5
- 229950001043 seviteronel Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 206010006187 Breast cancer Diseases 0.000 claims 3
- 208000026310 Breast neoplasm Diseases 0.000 claims 3
- 206010060862 Prostate cancer Diseases 0.000 claims 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 3
- 210000000481 breast Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762595918P | 2017-12-07 | 2017-12-07 | |
| US62/595,918 | 2017-12-07 | ||
| PCT/US2018/064229 WO2019113301A1 (en) | 2017-12-07 | 2018-12-06 | Compositions for the treatment of breast and prostate cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505669A JP2021505669A (ja) | 2021-02-18 |
| JP2021505669A5 true JP2021505669A5 (enExample) | 2022-01-11 |
| JP7437576B2 JP7437576B2 (ja) | 2024-02-26 |
Family
ID=66750338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550040A Active JP7437576B2 (ja) | 2017-12-07 | 2018-12-06 | 乳癌および前立腺癌の処置のための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210292410A1 (enExample) |
| EP (1) | EP3720427A4 (enExample) |
| JP (1) | JP7437576B2 (enExample) |
| CN (1) | CN111698985B (enExample) |
| AU (1) | AU2018380155B2 (enExample) |
| CA (1) | CA3084997A1 (enExample) |
| TW (1) | TWI809015B (enExample) |
| WO (1) | WO2019113301A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL266216B2 (en) | 2016-10-28 | 2023-09-01 | Morphosys Ag | Combination of anti-cd19 antibody with bcl-2 inhibitor and uses thereof |
| US12357615B2 (en) | 2018-10-11 | 2025-07-15 | Kembi Therapeutics Pty Ltd | Compositions for the treatment of brain tumors |
| US20220387394A1 (en) * | 2019-10-25 | 2022-12-08 | Garvan Institute Of Medical Research | Methods of treating cancer using androgen receptor antagonists |
| US12150776B2 (en) * | 2021-04-26 | 2024-11-26 | Wisconsin Alumni Research Foundation & AIQ Solutions, Inc. | System and method for monitoring multiple lesions |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| DK0431519T3 (da) | 1989-12-04 | 1994-07-04 | Searle & Co | System til transdermal indgivelse af albuterol |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| EP0553769B1 (de) | 1992-01-29 | 1996-01-03 | FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG | Ballspielschläger, insbesondere Tennisschläger |
| IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| CA2755976C (en) | 2009-03-23 | 2020-04-07 | Ambit Biosciences Corporation | Methods of treatment using combination therapy |
| AU2011326487B2 (en) * | 2010-11-13 | 2017-03-02 | Innocrin Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| JP2014525442A (ja) * | 2011-08-30 | 2014-09-29 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素阻害化合物 |
| US20150005265A1 (en) * | 2011-12-22 | 2015-01-01 | Susan Stewart | Methods and compositions for combination therapy using p13k/mtor inhibitores |
| CA3105575A1 (en) * | 2013-01-15 | 2014-07-24 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulator and uses thereof |
-
2018
- 2018-05-30 US US16/615,953 patent/US20210292410A1/en not_active Abandoned
- 2018-12-06 CN CN201880088898.9A patent/CN111698985B/zh active Active
- 2018-12-06 CA CA3084997A patent/CA3084997A1/en active Pending
- 2018-12-06 EP EP18886652.9A patent/EP3720427A4/en active Pending
- 2018-12-06 AU AU2018380155A patent/AU2018380155B2/en active Active
- 2018-12-06 WO PCT/US2018/064229 patent/WO2019113301A1/en not_active Ceased
- 2018-12-06 JP JP2020550040A patent/JP7437576B2/ja active Active
- 2018-12-07 TW TW107144106A patent/TWI809015B/zh active
-
2020
- 2020-06-05 US US16/894,732 patent/US11980626B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017226708A5 (enExample) | ||
| FI3788047T3 (fi) | Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi | |
| JP2021505669A5 (enExample) | ||
| WO2015097621A3 (en) | Pharmaceutical combinations | |
| JP2015536964A5 (enExample) | ||
| JP2016530280A5 (enExample) | ||
| JP2011079858A5 (enExample) | ||
| JP2015532292A5 (enExample) | ||
| JP2018508516A5 (enExample) | ||
| WO2016133903A3 (en) | Combination therapy for cancer treatment | |
| JP2016525097A5 (enExample) | ||
| JP2017506624A5 (enExample) | ||
| JP2019530706A5 (enExample) | ||
| JP2018522028A5 (enExample) | ||
| JP2014533277A5 (enExample) | ||
| JP2018530578A5 (enExample) | ||
| JP2017503014A5 (enExample) | ||
| JP2017536408A5 (enExample) | ||
| JP2019532047A5 (enExample) | ||
| JP2019526559A5 (enExample) | ||
| JP2017512194A5 (enExample) | ||
| JP2019506392A5 (enExample) | ||
| JP2019509253A5 (enExample) | ||
| JP2015507020A5 (enExample) | ||
| JP2010528091A5 (enExample) |